Test-retest reliability and concurrent validity of the Morrow Assessment of Nausea and Emesis (MANE) for the assessment of cancer chemotherapy-related nausea and vomiting

C. L.M. Carnrike, Phillip J. Brantley, Barbara Bruce, Shaista Faruqui, Frank M. Gresham, Ray R. Buss, Thomas B. Cocke

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

The present study evaluated the concurrent validity of two assessment approaches for the measurement of cancer chemotherapy-related nausea and vomiting. The results indicated that the concurrent validity between the Morrow Assessment of Nausea and Emesis (MANE; Morrow, 1984b) and continuous self-monitoring and the reliability on the MANE were moderate. The heterotrait-monomethod and heterotrait-heteromethod matrices demonstrated moderate correlations among the frequency, severity, and duration of anticipatory nausea and vomiting as well as high correlations among the frequency, severity, and duration of posttreatment nausea and vomiting. Additionally, the heterotrait-monomethod matrices show a number of correlations above chance between anticipatory and posttreatment symptoms. The results are discussed in light of future research endeavors.

Original languageEnglish (US)
Pages (from-to)107-116
Number of pages10
JournalJournal of Psychopathology and Behavioral Assessment
Volume10
Issue number2
DOIs
StatePublished - Jun 1 1988
Externally publishedYes

Keywords

  • cancer
  • nausea
  • reliability
  • validity
  • vomiting

ASJC Scopus subject areas

  • Clinical Psychology

Fingerprint Dive into the research topics of 'Test-retest reliability and concurrent validity of the Morrow Assessment of Nausea and Emesis (MANE) for the assessment of cancer chemotherapy-related nausea and vomiting'. Together they form a unique fingerprint.

  • Cite this